Companies / Lithuania
Sanitas Growing Strongly In CEE
June 2008 | Company News AlertLithuanian pharmaceutical group Sanitas has posted impressive Q108 results, with year-on-year (y-o-y) revenues up by 26% from LTL77.0mn (US$35.3) to LTL96.7mn (US$44.3mn). The group also improved its profit margins, which contributed to a 66% increase in y-o-y net profits to LTL10.3
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
